<DOC>
	<DOCNO>NCT02194400</DOCNO>
	<brief_summary>A one month multi-dose study evaluate safety tolerability 3 intravenous infusion RSLV-132 subject inactive mild SLE .</brief_summary>
	<brief_title>Dose Escalation Study RSLV-132 Subjects With Systemic Lupus Erythematosus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Stable SLE anticipate change medication next 60 day Other biologic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>RSLV-132</keyword>
	<keyword>Systemic Lupus Erythematosus</keyword>
	<keyword>Lupus</keyword>
	<keyword>SLE</keyword>
	<keyword>Resolve</keyword>
</DOC>